Search | Médecins Sans Frontières Access Campaign

23 results found

Statement |

08 December 2016

Médecins Sans Frontières UNAIDS PCB Intellectual Property intervention

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines intellectual property & tradeUN High Level Panel on Access to Medicines

Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines. Protest was done during 6th RCEP negotiationin India, 2014.

Opinion article |

02 December 2016

On World AIDS Day, threat to access to medicines looms large

Today millions of people living with HIV in South-East Asia are receiving treatment and leading healthy lives thanks to affordable generic antiretroviral (ARVs) medicines.

Tags Intellectual property and trade HIV/AIDStuberculosis access to medicinesgeneric medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP) World AIDS Day ASEAN

Statement |

27 July 2015

WIPO Standing Committee on the Law of Patents, 22nd Session

Tags Intellectual property and trade drug-resistant TBEbolahepatitis C World Health Organization

Metro advertisements for Doctors Without Borders, 2015.

Opinion article |

24 July 2015

TPP: Don’t trade away health

Tags Intellectual property and trade tuberculosishepatitis CHIV/AIDS evergreeningfree trade agreementintellectual property & tradeTrans-Pacific Partnership Agreement (TPP)

Opinion article |

24 July 2015

Why the TPP trade deal is a threat to public health

Tags Intellectual property and trade HIV/AIDS free trade agreementgeneric medicinesintellectual property & tradeTrans-Pacific Partnership Agreement (TPP) Democratic Republic of the Congo

Statement |

30 April 2014

MSF responds to US Trade 301 Watch List

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines evergreeningfree trade agreementTrans-Pacific Partnership Agreement (TPP)TRIPS PEPFARPHARMACEUTICAL Companies India

Statement |

02 April 2014

Submission to the US Trade Representative Regarding the 2014 Special 301 Review Process

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines free trade agreementTrans-Pacific Partnership Agreement (TPP)TRIPS PEPFAR India

Statement |

01 October 2013

MSF response to launch of the “Roadmap for childhood tuberculosis: towards zero deaths”

Tags Intellectual property and tradeTuberculosis tuberculosisdrug-resistant TB

Statement |

27 June 2013

Oral Testimony at US Congressional Hearing: “A Tangle of Trade Barriers: How India’s Industrial Policy is Hurting U.S. Companies.”

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines compulsory licencefree trade agreementuniversal access Novartis India

Opinion article |

15 April 2013

The EU must show leadership in the global fight against HIV/AIDS

Tags Intellectual property and trade HIV/AIDS European Commission

Opinion article |

30 November 2012

Canada’s role in ‘getting to zero’ on HIV

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines Trans-Pacific Partnership Agreement (TPP) World AIDS Day

Statement |

21 August 2012

Bayer/Natco compulsory licence appeal – hearings postponed

Tags Intellectual property and trade HIV/AIDS compulsory licence Bayer India

Opinion article |

07 August 2012

Do No Harm: How a US-Led Free Trade Agreement Threatens the Prospects for an AIDS-Free Generation

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines Trans-Pacific Partnership Agreement (TPP) International AIDS Conference

Opinion article |

27 July 2012

Right of people to affordable access to medicines

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines International AIDS Conference Myanmar

Opinion article |

06 January 2012

False positive HIV tests: the problem no one wants to talk about (and how to solve it)

Tags HIV/AIDSIntellectual property and trade HIV/AIDS diagnostic tests ICASA

Opinion article |

05 January 2012

ICASA conference: donor retreat and its consequences for patients and communities

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines ICASAPEPFAR

Opinion article |

03 January 2012

MSF: Initial outcomes of combination treatment for HIV and visceral leishmaniasis co-infection

Tags HIV/AIDSIntellectual property and tradeTropical & neglected diseases co-infectionHIV/AIDSvisceral leishmaniasis (kala azar) antiretroviral medicines ICASA Ethiopia

Vimbai Chitani (15) is a patient enrolled in the MSF HIV/AIDS project in Epworth, an urban settlement adjacent to the capital Harare of Zimbabwe.

Opinion article |

21 December 2011

Stop deaths, not funding

Tags HIV/AIDSIntellectual property and tradeMalariaTuberculosis tuberculosisdrug-resistant TBHIV/AIDSmalaria

Opinion article |

08 December 2011

Visceral leishmaniasis/HIV co-infection in East Africa

Tags Intellectual property and tradeTropical & neglected diseases visceral leishmaniasis (kala azar)co-infectionHIV/AIDS ICASADNDi EthiopiaSudan

Statement |

10 March 2011

MSF Oral Statement Regarding the 2011 Special 301 Review Process

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines free trade agreement

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Médecins Sans Frontières UNAIDS PCB Intellectual Property intervention

On World AIDS Day, threat to access to medicines looms large

WIPO Standing Committee on the Law of Patents, 22nd Session

TPP: Don’t trade away health

Why the TPP trade deal is a threat to public health

MSF responds to US Trade 301 Watch List

Submission to the US Trade Representative Regarding the 2014 Special 301 Review Process

MSF response to launch of the “Roadmap for childhood tuberculosis: towards zero deaths”

Oral Testimony at US Congressional Hearing: “A Tangle of Trade Barriers: How India’s Industrial Policy is Hurting U.S. Companies.”

The EU must show leadership in the global fight against HIV/AIDS

Canada’s role in ‘getting to zero’ on HIV

Bayer/Natco compulsory licence appeal – hearings postponed

Do No Harm: How a US-Led Free Trade Agreement Threatens the Prospects for an AIDS-Free Generation

Right of people to affordable access to medicines

False positive HIV tests: the problem no one wants to talk about (and how to solve it)

ICASA conference: donor retreat and its consequences for patients and communities

MSF: Initial outcomes of combination treatment for HIV and visceral leishmaniasis co-infection

Stop deaths, not funding

Visceral leishmaniasis/HIV co-infection in East Africa

MSF Oral Statement Regarding the 2011 Special 301 Review Process